Natural Biocon Current Share Price | Natural Biocon Stock Screener
NATURAL
Pesticides & Agrochemicals
Natural Biocon Current Stock Price Today
Live Share Price BSE
₹3.20
▼
-0.02 (-0.62%)
As of September 18, 2026, the live Natural Biocon share price (BSE: NATURAL) is ₹3.20, down 0.62% from the previous close, with shares trading between ₹3.17 and ₹3.32 in today's trading session, and a 52-week range of ₹3.20–₹6.46.
Browse NATURAL cash flow statement to support your investment research.
Use the Natural Biocon stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Natural Biocon Market Cap
₹8.99 Cr.
NATURAL P/E Ratio (TTM)
-50.57
Natural Biocon P/B Ratio
0.30
EPS (TTM)
₹-0.02
Dividend Yield
-
Debt to Equity
0.01
NATURAL 52 Week High
₹6.46
Natural Biocon 52 Week Low
₹3.20
Operating Margin
-3.00%
Profit Margin
-
NATURAL Revenue (TTM)
₹1.00
EBITDA
-
Net Income
-
Total Assets
₹37.00
Total Equity
₹31.00
Natural Biocon Current Share Price Chart
Track the current Natural Biocon share price and stock price with an interactive chart. Analyse NATURAL price trends, trading volume, historical performance, and volatility across different timeframes — the complete Natural Biocon stock quote in one place.
Natural Biocon Company Profile - Fundamental Screener
Screen Natural Biocon company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for NATURAL shares.
Sector
Chemicals
Industry
Pesticides & Agrochemicals
Sub-Sector
Pesticides & Agrochemicals
Segment
E
ISIN
INE06MM01016
Natural Biocon Balance Sheet Screener
Screen NATURAL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 37 | 39 | 17 | 14 | 12 | 12 | 13 | 13 | 13 | 12 |
| Current Assets | 5 | 7 | 6 | 2 | 1 | 2 | 2 | 2 | 2 | 1 |
| Fixed Assets | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 31 | 32 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 |
| Share Capital | 26 | 26 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves & Surplus | 5 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Natural Biocon Income Statement Screener - Profit & Revenue Analysis
Screen Natural Biocon income statement and profit fundamentals.
Analyze NATURAL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Natural Biocon share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 3 | 8 | 14 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Expenses | 1 | 3 | 8 | 13 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Operating Profit % | -3.00% | -1.00% | 1.00% | 2.00% | 20.00% | 18.00% | 3.00% | 0.00% | 25.00% | 96.00% | 71.00% | -1.00% | -4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| EPS | -0.10 | -0.02 | 0.02 | 0.13 | 0.16 | 0.01 | 0.00 | -0.07 | 0.06 | 0.62 | 0.01 | 0.00 | 0.00 |
Natural Biocon Cash Flow Screener - Liquidity Fundamentals
Screen NATURAL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| Investing Activities | -21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 20 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Natural Biocon Shareholding Pattern Screener
See Natural Biocon shareholding pattern with promoter, FII, and DII holdings.
Check Natural Biocon promoter holding and ownership changes for NATURAL on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | 21.22% | 21.22% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 49.60% | 49.64% | 33.35% | 53.82% | 50.74% | 47.93% | 74.90% | 74.90% |
| Other Holding | 41.04% | 41.00% | 57.29% | 36.82% | 39.90% | 42.71% | 3.88% | 3.88% |
| Shareholder Count | 11,027 | 11,352 | 9,097 | 8,737 | 9,541 | 10,166 | 7,824 | 7,824 |
Natural Biocon Share Dividend Screener - Share Yield Analysis
Check Natural Biocon dividend history with payout and yield data.
View Natural Biocon dividend details including ex-dates and amounts for NATURAL stock.
Natural Biocon Stock Index Membership
See which indices include Natural Biocon stock.
Check NATURAL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Natural Biocon Market Events Screener - Corporate Actions
Get Natural Biocon corporate actions including splits, bonuses, and buybacks.
Check Natural Biocon stock events that may affect NATURAL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -3.35% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | -24.64% |
| 2026-07-04 | 2026-07-04 | Annual General Meeting | NA | 0.58% |
| 2026-05-09 | 2026-05-09 | Quarterly Result Announcement | NA | -7.50% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 1.69% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -4.91% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -0.16% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -1.39% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 11.55% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 6.93% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -2.61% |
| 2024-11-29 | 2024-11-29 | Extraordinary General Meeting | NA | 4.12% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | -1.27% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -3.42% |
| 2024-05-23 | 2024-05-23 | Extraordinary General Meeting | NA | 10.80% |
Natural Biocon Competitors Screener - Peer Comparison
Screen NATURAL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| UPL | 47,341 | 20.84 | 52,502 | 11.41% | 2,220 | 40.11 |
| PI Industries | 34,212 | 29.40 | 7,024 | -15.59% | 1,321 | 26.07 |
| Sumitomo Chemical | 22,559 | 41.09 | 3,385 | 3.56% | 543 | 23.12 |
| Bayer Crop Science | 17,712 | 24.43 | 5,770 | 3.16% | 689 | 34.29 |
| Sharda Cropchem | 6,797 | 11.04 | 5,410 | 23.53% | 681 | 37.18 |
| Dhanuka Agritech | 4,312 | 14.71 | 2,071 | 15.49% | 297 | 35.51 |
| Rallis | 3,905 | 31.33 | 2,631 | 6.54% | 164 | 26.72 |
| NACL Industries | 3,512 | 297.45 | 1,587 | 27.74% | 5 | 27.53 |
| Bhagiradha Chemicals & Industries | 3,242 | 121.44 | 538 | 19.68% | 18 | 30.55 |
| GSP Crop Science | 2,197 | 22.26 | 1,531 | 17.66% | 95 | 24.56 |
Natural Biocon Company Announcements - News Screener
Screen NATURAL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On 08 September 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-09-08 | Board Meeting Outcome for AGM | - |
| 2026-09-01 | Board Meeting Intimation for AGM | - |
| 2026-08-14 | Quarterly Results June 30 2026 | - |
| 2026-08-14 | Board Meeting Outcome for Quarterly Results June 30 2026 | - |
| 2026-08-11 | Board Meeting Intimation for Quarterly Results June 30 2026 | - |
| 2026-07-14 | Board Meeting Outcome for Resignation Of Directors | - |
| 2026-07-11 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-18 | Closure of Trading Window | - |
| 2026-06-06 | Board Meeting Outcome for AGM | - |
| 2026-06-05 | Board Meeting Outcome for Appointment Of Ms. Shruti Sharma (M. No.: A52723) As Company Secretary And Compliance Officer Of The Company W.E.F. 05Th June 2026. | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-28 | Board Meeting Intimation for Details Related To AGM | - |
| 2026-05-28 | Unable To Conduct Board Meeting On 18Th May 2026 | - |
| 2026-05-11 | Board Meeting Intimation for AGM | - |
| 2026-05-09 | Audited Financial Results For The Quarter And Year Ended March 2026 | - |
| 2026-05-09 | Board Meeting Outcome for Audited Financial Results Along With Auditors Report For The Quarter And Year Ended March 2026 | - |
| 2026-04-30 | Board Meeting Intimation for Audited Results And Audit Report | - |
| 2026-04-28 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-22 | Board Meeting Intimation for Audited Financial Result For The Quarter And Financial Year Ended On 31St March 2026 Along With The Auditors Report. | - |